Galectin Therapeutics (GALT) Non-cash Items (2012 - 2025)

Galectin Therapeutics' Non-cash Items history runs 11 years deep, the most recent figure standing at $13.0 million for Q4 2025.

• In Q4 2025, Non-cash Items rose 7020.77% year-over-year to $13.0 million; the TTM figure through Dec 2025 stood at $13.0 million (up 7020.77% YoY), while the FY2025 annual figure was $13.0 million, up 7020.77% from the prior year.
• Non-cash Items was $13.0 million for Q4 2025 at Galectin Therapeutics, up from $183000.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $13.0 million in Q4 2025 to a low of $183000.0 in Q4 2024.
• Historically, Non-cash Items has averaged $4.7 million across 5 years, with a median of $3.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items tumbled 95.97% in 2024, then surged 7020.77% in 2025.
• A 5-year view of Non-cash Items shows it stood at $2.2 million in 2021, then jumped by 64.53% to $3.6 million in 2022, then advanced by 27.89% to $4.5 million in 2023, then sank by 95.97% to $183000.0 in 2024, then soared by 7020.77% to $13.0 million in 2025.
• The last three Non-cash Items figures came in at $13.0 million (Q4 2025), $183000.0 (Q4 2024), and $4.5 million (Q4 2023), per Business Quant data.